Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Shashank Sinha

Advanced Heart Failure · Inova Fairfax Hospital

View

Dr. Javed Butler

Advanced Heart Failure · Baylor Health Care System

View

Dr. Andrew Sauer

Advanced Heart Failure · Saint Luke's

View

Dr. Anu Lala

Advanced Heart Failure · Mount Sinai

View

Dr. Robert Mentz

Advanced Heart Failure · Duke University

View

Dr. Sunny Varshney

Advanced Heart Failure · Stanford

View

Dr. Stephanie Hsiao

Advanced Heart Failure · Stanford

View

Dr. Michelle Kittleson

Advanced Heart Failure · Cedars-Sinai

View

Dr. Adrian Hernandez

Advanced Heart Failure · Duke

View

Dr. Dorairaj Prabhakaran

General Cardiology

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    KSDr. Kavita Sharma

    Dr. Kavita Sharma

    Cardiology · Advanced Heart Failure & Transplantation
    Johns Hopkins Medicine
    kavita

    Research

    Sacubitril/valsartan versus valsartan initiation in patients naïve to renin-angiotensin system inhibitors: Insights from PARAGLIDE-HF

    2025

    Via European Journal of Heart Failure

    Research

    Six-Month Outcomes in the Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children Study

    2025

    Via JAMA Pediatrics

    Jan 22, 2025Journal Article

    Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting.

    ​
    ​

    Written by 2 Roon authors & 9 others

    Via The American Heart Association Journals

    Research

    Monocytes and interstitial macrophages contribute to hypoxic pulmonary hypertension

    2025

    Via The Journal of Clinical Investigation

    Feb 19, 2025Journal Article

    In-Hospital or Out-of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE-HF Trial.

    ​

    Written by 1 Roon author & 13 others

    Via The American Heart Association Journals

    Research

    Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF: The HuMAIN-HFpEF Randomized Clinical Trial

    2025

    Via JAMA Cardiology

    Mar 13, 2025Journal Article

    Myocardial Proteome in Human Heart Failure With Preserved Ejection Fraction.

    ​

    Written by 1 Roon author & 12 others

    Via The American Heart Association Journals

    Research

    Understanding preservation time thresholds in the modern era of heart transplantation

    2025

    Via Scientific Reports

    Research

    High rate of false negative Tc-pyrophosphate scintigraphy scans in patients with Leu58His transthyretin amyloid cardiomyopathy

    2025

    Via Amyloid

    Research

    ATP-Citrate Lyase Supports Cardiac Function and NAD/NADH Balance and Is Depressed in Human Failing Myocardium

    2025

    Via JACC. Basic to Translational Science

    Research

    Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction Diagnosis: An Update From the American Society of Echocardiography

    2025

    Via Journal of the American Society of Echocardiography

    Research

    Reply to The Need for Obesity-Specific Considerations in the Updated American Society of Echocardiography Recommendations for Evaluation of Diastolic Function

    2025

    Via Journal of the American Society of Echocardiography

    Aug 22, 2025Journal Article

    Cardiac Magnetic Resonance Imaging in Heart Failure With Preserved Ejection Fraction.

    ​

    Written by 1 Roon author & 5 others

    Via The American Heart Association Journals

    Research

    Congestion and Low Cardiac Output Hemodynamic Phenotype Drives Outcomes in Overweight and Obese HFpEF

    2025

    Via JACC. Heart Failure

    Research

    A comparison of single versus combination mechanism treatment for transthyretin amyloid cardiomyopathy

    2025

    Via Amyloid